A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2− Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.
Simple Summary: Drugs known as cyclin-dependent kinase 4/6 inhibitors are commonly used together with hormone therapy as the first treatment for people with hormone receptor-positive, HER2-negative advanced breast cancer. However, these drugs have not been directly compared in large clinical trials....
| Publicado en: | Cancers Vol. 18; no. 14; pp. 2362 - 2385 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
MDPI
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |